GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Pretax Margin %

BIOA (Bioage Labs) Pretax Margin % : % (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Bioage Labs's Pre-Tax Income for the three months ended in Sep. 2024 was $-23.41 Mil. Bioage Labs's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Bioage Labs's pretax margin for the quarter that ended in Sep. 2024 was %.

The historical rank and industry rank for Bioage Labs's Pretax Margin % or its related term are showing as below:


BIOA's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.235
* Ranked among companies with meaningful Pretax Margin % only.

Bioage Labs Pretax Margin % Historical Data

The historical data trend for Bioage Labs's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Pretax Margin % Chart

Bioage Labs Annual Data
Trend Dec22 Dec23
Pretax Margin %
- -

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Bioage Labs's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioage Labs's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Bioage Labs's Pretax Margin % falls into.


Bioage Labs Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Bioage Labs's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-63.854/0
= %

Bioage Labs's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-23.407/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs  (NAS:BIOA) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Bioage Labs Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Pretax Margin %
Comparable Companies
Traded in Other Exchanges
N/A
Address
1445A South 50th Street, Richmond, CA, USA, 94804
Website
https://www.bioagelabs.com
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.